Seven Eight Capital’s Esperion Therapeutics ESPR Stock Holding History

Seven Eight Capital’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-18,941	Closed	-$704K	–	473
2020 Q3	$704K	Buy	+18,941	New	+$750K	0.15%	258
2018 Q4	–	Sell	-8,707	Closed	-$386K	–	583
2018 Q3	$386K	Sell	8,707 -13,600	-61%	-$624K	0.02%	485
2018 Q2	$874K	Buy	+22,307	New	+$1.13M	0.06%	303
2017 Q4	–	Sell	-23,398	Closed	-$1.17M	–	487
2017 Q3	$1.17M	Buy	23,398 +21,531	+1,153%	+$1.04M	0.14%	227
2017 Q2	$86K	Buy	+1,867	New	+$68.7K	0.01%	445
2015 Q2	–	Sell	-3,500	Closed	-$324K	–	563
2015 Q1	$324K	Buy	+3,500	New	+$226K	0.54%	49

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return